We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
The ongoing rifts between HHS and the FDA continued this week with confusion surrounding the department’s selection of James Lawrence as the agency’s chief counsel, just hours after FDA Commissioner Stephen Hahn announced a different pick to agency staff. Read More
AstraZeneca (AZ) has filed for EU approval of its COVID-19 vaccine and a conditional marketing authorization is expected in late January following a Jan. 29 meeting of the European Medicines Agency’s (EMA) expert panel on human medicines. Read More
Moderna is following up on the success of its messenger RNA-based COVID-19 vaccine with plans to develop inoculations for numerous other infectious diseases, the company said Monday. Read More
COVID-19 patients on intensive care support did not see improvement when given convalescent plasma, according to preliminary findings from the UK arm of a global trial. Read More
Pfizer and BioNTech now anticipate manufacturing up to 2 billion doses of their highly effective COVID-19 vaccine by the end of the year as vaccination efforts ramp up and demand for shots increases around the globe. Read More
A phase 2 trial of Eli Lilly’s investigational Alzheimer’s drug donanemab demonstrated a “significant slowing of decline” in early Alzheimer’s patients who exhibited symptoms, the company revealed Monday. Read More